Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

EVEREST ORGANICS Plunges 7%; BSE HEALTHCARE Index Up 1.1%
Fri, 22 Nov 13:24

EVEREST ORGANICS Plunges 7%; BSE HEALTHCARE Index Up 1.1%Image source: KanawatTH/www.istockphoto.com

EVEREST ORGANICS share price has plunged 7% and is presently trading at Rs 135.0.

Meanwhile, the BSE HEALTHCARE index is at 42,915.4 (up 1.1%).

Among the top losers in the BSE HEALTHCARE index today are GLAND PHARMA (down 1.2%) and Natco Pharma (down 1.2%).

SUN PHARMA ADV. RES. (up 8.1%) and LAURUS LABS (up 5.1%) are among the top gainers today.

Over the last one year, EVEREST ORGANICS has moved up from Rs 116.0 to Rs 135.0, registering a gain of Rs 19.0 (up 16.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,583.1 to 42,915.4, registering a gain of 45.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 161.2%), SUVEN PHARMACEUTICALS (up 118.3%) and FORTIS HEALTHCARE (up 88.5%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 78,306.3 (up 1.5%).

The top gainers among the BSE Sensex today are SBI (up 3.7%) and Ultratech Cement (up 2.6%). The most traded stocks in the BSE Sensex are Power Grid Corp. and MUNDRA PORT & SEZ.

In the meantime, NSE Nifty is at 23,729.7 (up 1.6%). SBI and Tata Consumer Products are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,655.2 to 78,306.3, registering a gain of 12,651.1 points (up 19.3%).

EVEREST ORGANICS Financial Update...

EVEREST ORGANICS net profit grew 2451.7% YoY to Rs 7 million for the quarter ended September 2024, compared to a profit of Rs 0 million a year ago. Net sales declined 10.9% to Rs 440 million during the period as against Rs 494 million in July-September 2023.

For the year ended March 2024, EVEREST ORGANICS reported 176.4% increase in net profit to Rs 1 million compared to net loss of Rs 2 million during FY23. Revenue of the company grew 6.8% to Rs 1,680 million during FY24.

The current Price to earnings ratio of EVEREST ORGANICS, based on rolling 12 month earnings, stands at -20.5.


Equitymaster requests your view! Post a comment on "EVEREST ORGANICS Plunges 7%; BSE HEALTHCARE Index Up 1.1%". Click here!